CRA consultants supported a pharmaceutical company in its successful challenge of an ANDA filed by a generic manufacturer. The generic company sought to manufacture and sell generic versions of two related diabetes treatments. CRA provided a report analyzing evidence of commercial success for the branded pharmaceutical products as well as deposition and trial testimony.
An economic analysis of the artificial intelligence-copyright nexus
Among the large number of policy issues that are raised by the introduction and expanded use of Artificial Intelligence (“AI”) – its potential for the creation...